What did Audeara (ASX:AUA) announce regarding its partnership with Shokz?

Audeara has secured an exclusive Australian agreement with Shokz Health Global to deploy the OpenLearn Small, a customised assistive listening solution.

What is the target market for the Audeara (ASX:AUA) OpenLearn Small device?

The product specifically targets the approximately 600,000 school-aged children in Australia who experience functional listening challenges. These issues are frequently linked to fluctuating hearing loss, which can impede classroom participation and academic performance.

How does the Shokz technology differ from standard headphones?

The OpenLearn Small uses bone conduction technology, which transmits sound through the cheekbones directly to the inner ear, leaving the ear canal open. This non-invasive, open-ear design allows students to hear the device's audio while remaining aware of their physical environment and teacher instructions.

How does this deal affect the Audeara (ASX:AUA) investment thesis?

This agreement signals a shift toward a more scalable, B2G (business-to-government) and B2B model rather than relying solely on individual consumer sales. By aligning with a global leader like Shokz, Audeara validates its audio tuning expertise and gains a high-quality hardware partner.

What are the primary revenue drivers for this new agreement?

Revenue is expected to be driven through "fully funded" state and national government programs and charitable channels. Rather than traditional retail, this creates a pathway where the government or NGOs cover the costs for the end-user, potentially leading to more stable and predictable order volumes.

What was the Audeara (ASX:AUA) share price at the time of the news?

At the time of reporting, Audeara’s share price was $0.057. As a micro-cap stock on the ASX, investors should note that news of exclusive partnerships can cause higher-than-average volatility.

What are the key risks for Audeara (ASX:AUA) following this announcement?

The main risks involve execution and the speed of government funding cycles. While the "pathway" to government programs exists, securing actual budget allocations and navigating bureaucratic procurement processes can be slow.

What should investors watch for in the next Audeara (ASX:AUA) quarterly report?

Investors should look for updates on the "Product Customisation" phase and any initial orders placed by government or charitable entities.

Tech

Audeara secures ShokzHear assistive listening deal

Written by Mahathir BayenaPublished Apr. 16 2026Last Updated Apr. 16 2026

Audeara (ASX:AUA) announced an exclusive agreement with Shokz Health Global to deploy the customised OpenLearn Small assistive listening solution.

The partnership marks a milestone for Audeara, as it integrates Shokz's world-leading bone conduction technology with its own specialised audio tuning expertise to address an urgent and underserved market.

The collaboration targets the estimated 600,000 school-aged children across Australia who face functional listening challenges.

The difficulties, often stemming from fluctuating hearing loss, can severely hinder a child’s ability to participate in the classroom and achieve long-term academic success.

By providing a non-invasive, open-ear listening device, the OpenLearn Small is designed to support these students during their most critical learning years, particularly those in regional and remote communities where access to specialised care can be limited.

Under the terms of the product customisation and market deployment agreement, ShokzHear will manufacture a version of its technology specifically tailored to Audeara’s requirements regarding size, functionality, and audio parameters for the Australian market.

The agreement establishes a scalable commercial pathway through fully funded state and national government programmes, as well as charitable channels.

At the time of reporting, Audeara’s share price was $0.057.